HomeAKYA • NASDAQ
add
Akoya Biosciences Inc
Previous close
$1.33
Day range
$1.31 - $1.37
Year range
$0.93 - $3.42
Market cap
67.12M USD
Avg Volume
818.13K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 16.64M | -9.32% |
Operating expense | 23.14M | -8.97% |
Net income | -15.65M | 33.35% |
Net profit margin | -94.07 | 26.50% |
Earnings per share | -0.32 | 7.79% |
EBITDA | -11.47M | 23.48% |
Effective tax rate | -0.31% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 27.54M | -55.27% |
Total assets | 112.65M | -27.21% |
Total liabilities | 118.54M | -2.86% |
Total equity | -5.89M | — |
Shares outstanding | 49.88M | — |
Price to book | -11.08 | — |
Return on assets | -27.91% | — |
Return on capital | -39.12% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.65M | 33.35% |
Cash from operations | -7.21M | 65.36% |
Cash from investing | 16.04M | 132.87% |
Cash from financing | -250.00K | 43.69% |
Net change in cash | 8.58M | 112.24% |
Free cash flow | -764.75K | 93.70% |
About
Founded
2015
Headquarters
Website
Employees
205
